[1]朱苗蕊,指导:金智生.糖脂平治疗早期糖尿病肾病60例疗效观察*[J].西部中医药,2013,26(03):74-75.
 ZHU Miaorui,Director: JIN Zhisheng.Clinical Observation on TangZhiPing in Treating 60 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(03):74-75.
点击复制

糖脂平治疗早期糖尿病肾病60例疗效观察*
分享到:

《西部中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
26
期数:
2013年03期
页码:
74-75
栏目:
报道·临证经验
出版日期:
2013-03-15

文章信息/Info

Title:
Clinical Observation on TangZhiPing in Treating 60 Cases of Early Diabetic Nephropathy
文章编号:
1004-6852(2013)03-0074-02
作者:
朱苗蕊指导:金智生
甘肃中医学院,甘肃 兰州 730000
Author(s):
ZHU MiaoruiDirector: JIN Zhisheng
Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China
关键词:
糖尿病肾病糖脂平治疗
Keywords:
diabetic nephropathy TangZhiPing treatment
分类号:
R587.2
文献标志码:
B
摘要:
目的:观察糖脂平加减治疗早期糖尿病肾病的临床疗效。方法:将 60 例早期糖尿病肾病患者分为对照组、治疗组各 30 例。2 组均给予拜阿司匹林、瑞格列奈、血塞通等常规治疗。治疗组同时加用糖脂平,1 剂 /d,水煎服,200 mL/ 次,2 次 /d。2 组均以治疗 15 天为 1 个疗程。治疗期间监测血压及血糖。结果:显效率对照组为 40.00%,治疗组为 60.00%,2 组相比差异有统计学意义(P<0.05);总有效率对照组为 73.33%,治疗组为 83.33%,2 组相比差异有统计学意义(P<0.05)。Scr、TG、TC、β2-MG、mAlb 等指标治疗组改善较对照组明显,2 组相比差异有统计学意义(P<0.05)。结论:糖脂平治疗早期糖尿病肾病疗效满意。
Abstract:
Objective: To observe clinical effects of modified TangZhiPing capsules in treating early diabetic nephropathy. Method: Sixty patients were allocated into the control group and the treatment group equally. Both groups received routine treatment including aspirin enteric-coated tablets, repaglinide, XueSaiTong injection and others. The treatment groups took TangZhiPing, one dose each day, water decocted, 200mL/time, twice per day. One course of treatment was 15 days. Blood pressure and glucose were monitored during the treatment. Result: Effectual rate of the control group was 40.00%, lower than 60.00% of the treatment group with statistical meaning (P< 0.05);Total effective rate of the control group was 73.33% , less than 83.33% of the treatment group with statistical meaning (P< 0.05). The treatment group improved greater than the control group in Scr, TG, TC, β2-MG, mAlb and other indexes, comparisons between both groups showed statistical meaning (P< 0.05). Conclusion: TangZhiPing in treating early diabetic nephropathy could obtain satisfactory effects.

参考文献/References:

[1] 陈茜,孙伟.中医诊治糖尿病肾病伴蛋白尿的研究进展[J].西部中医药,2012,25(3):104-108. [2] 陆菊明,潘长玉.糖尿病肾病的流行病学和诊断标准[J].中华老年多器官疾病杂志,2002,1(3):163-165. [3] 郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:104-108. [4] 罗明祥.中西医结合治疗早期糖尿病肾病 42 例[J].西部中医药,2011,24(7):82-83. [5] 刘立昌,刘新,冯敏坚,等.壮肾固精方治疗糖尿病肾病Ⅲ期的疗效观察[J].西部中医药,2012,25(4):11-12. [6] 陈莉娜.益肾降糖丸配合西药治疗早期糖尿病肾病 60 例临床疗效观察[J].中国医药导报,2011,8(32):105-106. [7] 于梅,迟继铭,张岩岩,等.肾炎消白颗粒对早期糖尿病肾病患者尿白蛋白及血清 TGF-β1的影响[J].中医药信息,2012,29(1):43-44.

相似文献/References:

[1]连琯,史晓伟.当归补血汤合金水宝治疗早期糖尿病肾病16例临床观察[J].西部中医药,2013,26(06):68.
 LIAN Guan,SHI Xiaowei.Clinical Observation on DangGui BuXueTang and JinShuiBao in Treating 16 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(03):68.
[2]林晓芬,黄燕璇.益肾汤联合厄贝沙坦及胰激肽原酶治疗早期糖尿病肾病的疗效观察[J].西部中医药,2013,26(07):68.
 LIN Xiaofen,HUANG Yanxuan.Clinical Observation on YiShenTang Combined with Irbesartan and Pancreatic Kininogenase in the Treatment for Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(03):68.
[3]马天寿.血塞通联合西药治疗糖尿病肾病80例[J].西部中医药,2013,26(08):96.
 MA Tianshou.XueSaiTong Injection and Western Medicine in Treating 80 Cases of Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(03):96.
[4]王学琦,李丰华,张荣华,等.温肾汤治疗早期糖尿病肾病80例[J].西部中医药,2013,26(09):62.
 WANG Xueqi,LI Fenghua,ZHANG Ronghua,et al.WenShenTang for 80 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(03):62.
[5]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病随机对照试验报告质量评价[J].西部中医药,2013,26(12):1.
 REN Fang,XU Houqian.Quality Evaluation of the Report for Randomized Controlled Trials of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(03):1.
[6]杨华,曾娟花.血清TNF与2型糖尿病肾病及其中医证型关系的临床研究[J].西部中医药,2014,27(01):11.
 YANG Hua,ZENG Juanhua.Clinical Study on the Relationship between Serum TNF and Type 2 Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(03):11.
[7]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病有效性及安全性的系统评价[J].西部中医药,2014,27(01):77.
 REN Fang,XU Houqian.Systematic Review of the Effectiveness and Safety of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(03):77.
[8]丁夏楠,许筠△,苏建平,等.益肾逐瘀方治疗糖尿病肾病蛋白尿37例[J].西部中医药,2014,27(04):96.
 DING Xianan,XU Jun,SU Jianping,et al.Treatment for Proteinuria of 37 Patients with Diabetic Nephropathy by Kidney-invigorating Stagnation-dispelling Prescription[J].Western Journal of Traditional Chinese Medicine,2014,27(03):96.
[9]孙慧,李彩萍.雷公藤多苷联合二甲双胍治疗糖尿病肾病临床观察[J].西部中医药,2014,27(07):82.
 SUN Hui,LI Caiping.Clinical Observation on Tripterygium Glycosides and Metformin in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(03):82.
[10]肖远莉.循证护理的优效性及影响因素分析———来自终末期糖尿病肾病患者血液透析的证据[J].西部中医药,2014,27(08):127.

备注/Memo

备注/Memo:
收稿日期:2012-11-02 * 基金项目:教育部重点项目(编号 206150)、甘肃省科技支撑计划(编号 0708NKCA127) 作者简介:朱苗蕊(1979—),女,硕士研究生。研究方向:糖尿病的中西医结合诊治。
更新日期/Last Update: 2013-03-15